A Maryland University spinout is working on portable artificial lungs after gaining the rights to the technology and receiving a $100,000 investment.

Breethe, a Maryland University spinout that has created a portable lung, has received approval to licence its technology.

UM Ventures, the university’s commercialisation office, provided the company with permission to licence the technology it had developed. Breethe has the exclusive rights to this technology.

The system is a wearble, backpack-sized device that oxygenates the blood, acting as an artificial lung for patients that would usually be restricted to a respirator in a hospital.

Phil Robilotto, chief commercialisation officer, UM Ventures,…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?